150 related articles for article (PubMed ID: 10674767)
1. Topical treatment approved for fungal nail infection.
Miller JL
Am J Health Syst Pharm; 2000 Feb; 57(3):205. PubMed ID: 10674767
[No Abstract] [Full Text] [Related]
2. Ciclopirox nail lacquer topical solution 8%.
Gupta AK
Skin Therapy Lett; 2000; 6(1):1-5. PubMed ID: 11027420
[TBL] [Abstract][Full Text] [Related]
3. Simplified experimental human dermatophytosis model.
Aly R; Maibach HI; Ho I; Abrams BB
Int J Dermatol; 1992 Feb; 31(2):122-5. PubMed ID: 1559737
[TBL] [Abstract][Full Text] [Related]
4. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
[TBL] [Abstract][Full Text] [Related]
5. Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris.
Bogaert H; Cordero C; Ollague W; Savin RC; Shalita AR; Zaias N
J Int Med Res; 1986; 14(4):210-6. PubMed ID: 3530834
[TBL] [Abstract][Full Text] [Related]
6. Tinea corporis bullosa due to Trichophyton schoenleinii: case report.
Mareş M; Năstasă V; Apetrei IC; Suditu GC
Mycopathologia; 2012 Oct; 174(4):319-22. PubMed ID: 22576942
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of the antifungal efficacy of poloxamer 407-based formulations in an infected nail plate model.
Täuber A; Müller-Goymann CC
Int J Pharm; 2016 May; 505(1-2):20-3. PubMed ID: 26992819
[TBL] [Abstract][Full Text] [Related]
8. In vitro model of infected stratum corneum for the efficacy evaluation of poloxamer 407-based formulations of ciclopirox olamine against Trichophyton rubrum as well as differential scanning calorimetry and stability studies.
Täuber A; Müller-Goymann CC
Int J Pharm; 2015 Oct; 494(1):304-11. PubMed ID: 26276254
[TBL] [Abstract][Full Text] [Related]
9. Ciclopirox nail lacquer: a brush with onychomycosis.
Gupta AK
Cutis; 2001 Aug; 68(2 Suppl):13-6. PubMed ID: 11665723
[TBL] [Abstract][Full Text] [Related]
10. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
[TBL] [Abstract][Full Text] [Related]
11. A-Detail fact sheet (Canada). Ciclopirox 8% nail lacquer (Penlac).
Skin Therapy Lett; 2005 Dec-2006 Jan; 10(10):suppl 1 p.. PubMed ID: 16518906
[No Abstract] [Full Text] [Related]
12. Ciclopirox: a new topical pyrodonium antimycotic agent. A double-blind study in superficial dermatomycoses.
Sehgal VN
Br J Dermatol; 1976 Jul; 95(1):83-8. PubMed ID: 782504
[TBL] [Abstract][Full Text] [Related]
13. Onychomycosis and AIDS: treatment with topical ciclopirox olamine.
Dompmartin D; Dompmartin A; Deluol AM; Coulaud JP
Int J Dermatol; 1990 Apr; 29(3):233. PubMed ID: 2139871
[No Abstract] [Full Text] [Related]
14. Successful treatment of onychomycosis with ciclopirox nail lacquer: a case report.
Galitz J
Cutis; 2001 Aug; 68(2 Suppl):23-4. PubMed ID: 11665725
[TBL] [Abstract][Full Text] [Related]
15. [Ciclopirox (Mycosten), topically].
J Pharm Belg; 2013 Sep; (3):47-8. PubMed ID: 24804412
[No Abstract] [Full Text] [Related]
16. Ciclopirox for the treatment of superficial fungal infections: a review.
Gupta AK; Skinner AR
Int J Dermatol; 2003 Sep; 42 Suppl 1():3-9. PubMed ID: 12895181
[TBL] [Abstract][Full Text] [Related]
17. [Ciclopiroxolamine. A pyridone derivative for local use in fungal infections of the skin and nails].
Svejgaard EL
Ugeskr Laeger; 1993 Mar; 155(10):733-5. PubMed ID: 8456522
[No Abstract] [Full Text] [Related]
18. Mycotic infections. Effective management of conditions involving the skin, hair, and nails.
Goldstein AO; Smith KM; Ives TJ; Goldstein B
Geriatrics; 2000 May; 55(5):40-2, 45-7, 51-2. PubMed ID: 10826264
[TBL] [Abstract][Full Text] [Related]
19. Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
Traynor MJ; Turner RB; Evans CR; Khengar RH; Jones SA; Brown MB
J Pharm Pharmacol; 2010 Jun; 62(6):730-7. PubMed ID: 20636860
[TBL] [Abstract][Full Text] [Related]
20. The use of 40% urea cream in the treatment of moccasin tinea pedis.
Elewski BE; Haley HR; Robbins CM
Cutis; 2004 May; 73(5):355-7. PubMed ID: 15186053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
